Pfizer Inc. diskutieren
Pfizer Inc.
WKN: 852009 / Symbol: PFE / Name: Pfizer / Aktie / Pharmazeutika / Large Cap /
25,83 €
-1,38 %
Buy Pfizer Inc.
Buy Pfizer Inc.
There is an uptrend with bullish momentum in the last month for this stock. According to the moving averages and technical indicators, there is a potential buy signal for a daily approach. In addition, the weekly approach shows a strong buy signal for Pfizer's stock. Technical Indicators show a strong buy and the moving averages show a potential buy signal.
Therefore, for investment with monthly duration, there is a buy signal for the above stock. Technical indicators and moving averages show a strong buy signal. Considering the financial measurements, high profitability, high RoA compared to the industry, and the healthy outlook of this firm, our research team suggests a buying movement.
Therefore, for investment with monthly duration, there is a buy signal for the above stock. Technical indicators and moving averages show a strong buy signal. Considering the financial measurements, high profitability, high RoA compared to the industry, and the healthy outlook of this firm, our research team suggests a buying movement.
.png?locale=de "FinanceClub_UoM")
Buy Pfizer Inc.
Buy Pfizer Inc.
Buy with target price 36.0
Buy with target price 72.0
Buy Pfizer Inc.
Sell with target price 30.0
Sell Pfizer Inc.
Buy Pfizer Inc.
Buy Pfizer Inc.
Buy with target price 42.0
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at BMO Capital Markets from $45.00 to $44.00. They now have an "outperform" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $75.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $75.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $75.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $62.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $75.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Home Depot Inc. diskutieren